Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad^® Efficacy and Safety (SMiLES)

REFERENCES

• Botter AA. Topical treatment of nail and skin infections with miconazole, a new broad-spectrum antimycotic. Mykosen. 1971;14(4):187–191.
   PubMedGoogle Scholar
• Quatresooz P, Vroome V, Borgers M, et al. Novelties in the multifaceted miconazole effects on skin disorders. Expert Opin Pharmacother 2008;9(11):1927–1934.
   PubMed Web of Science ®Google Scholar
• Fothergill AW. Miconazole: a historical perspective. Expert Rey Anti Infect Ther 2006;4(2):171–175.
   PubMedGoogle Scholar
• Francois IEJA, Cammune BPA, Borgers M, et al. Azoles: mode of antifungal action and resistance development. effect of miconazole on endogenous reactive oxygen spe-cies production in Candida albicans. Anti-Infect Agents Medicinal Chem. 2006;5:3–13.
   Google Scholar
• Shin ES, Chung SC, Kim YK, et al. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radio! Endod. 2003;96(1):48–53.
   PubMed Web of Science ®Google Scholar
• Epstein JB. Diagnosis and treatment of oropharyn-geal candidiasis. Oral Maxillofac Surg Clin North Am. 2003;15(1):91–102.
   PubMedGoogle Scholar
• Vazquez JA, Sobel JD. Mucosa! candidiasis. Infect Dis Clin North Am. 2002;16(4):793–820, v.
   PubMed Web of Science ®Google Scholar
• Arribas JR, Hernandez-Albujar S, Gonzalez-Garcia JJ, et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS. 2000;14(8):979–985.
   PubMed Web of Science ®Google Scholar
• Cauda R, Tacconelli E, Tumbarello M, et al. Role of pro-tease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J Acquir Immune Defic Syndr 1999;21(1):20–25.
   PubMed Web of Science ®Google Scholar
• Greenspan D, Canchola AJ, MacPhail LA, et al. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet. 2001;357(9266)1 411–1412.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes D, et al. Clinical prac-tice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–535.
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58( RR-4):1-207; quiz CE201–204.
   Google Scholar
• Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents. Drug interactions of clinical significance. Drug Saf. 1998;18(2):83–97.
   PubMed Web of Science ®Google Scholar
• Baccaglini L, Atkinson JC, Patton LL, et al. Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103 (Supp1:550):e51–23.
   PubMed Web of Science ®Google Scholar
• Cardot JM, Chaumont C, Dubray C, et al. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects. Br J Clin Pharmacol. 2004;58(4):345–351.
   PubMed Web of Science ®Google Scholar
• Murray PA, Koletar SL, Mallegol I, et al. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients. Clin Ther 1997;19(3):471–480.
   PubMed Web of Science ®Google Scholar
• Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533–551.
   PubMedGoogle Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Koletar SL, Russell JA, Fass RJ, et al. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother. 1990;34(11):2267–2268.
   PubMed Web of Science ®Google Scholar
• Linpiyawan R, Jittreprasert K, Sivayathorn A. Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treat-ment of oral candidosis in AIDS patients. Int J Dermatol. 2000;39(11):859–861.
   PubMed Web of Science ®Google Scholar
• Pons V, Greenspan D, Debruin M. Therapy for oropha-ryngeal candidiasis in HIV-infected patients: a random-ized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group. J Acquir Immune Defic Syndr 1993;6(12):1311–1316.
   PubMed Web of Science ®Google Scholar
• Redding SW, Farinacci GC, Smith JA, et al. A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection. Spec Care Dentist. 1992;12(1):24–27.
   PubMedGoogle Scholar
• Hughes WT, Bartley DL, Patterson GG, et al. Ketocon-azole and candidiasis: a controlled study. J Infect Dis. 1983;147(6):1060–1063.
   PubMed Web of Science ®Google Scholar
• Shechtman LB, Funaro L, Robin T, et al. Clotrimazole treatment of oral candidiasis in patients with neoplastic disease. Am J Med. 1984;76(1):91–94.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick CH, Ailing DW. Treatment of chronic oral can-didiasis with clotrimazole troches. A controlled clinical trial. N Engl J Med. 1978;299(22)1201–1203.
   Web of Science ®Google Scholar
• Pons V, Greenspan D, Lozada-Nur F, et al. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Clin Infect Dis 1997;24(6)1204–1207.
   Web of Science ®Google Scholar
• Van Roey J, Haxaire M, Kamya M, et al. Comparative effi-cacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus sys-temic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr 2004;35(2):144–150.
   PubMed Web of Science ®Google Scholar
• Vazquez JA, Skiest DJ, Nieto L, et al. A multicenter randomized trial evaluating posaconazole versus flu-conazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin Infect Dis. 2006;42(8): 1179–1186.
   PubMed Web of Science ®Google Scholar
• Elad S, Wexler A, Garfunkel AA, et al. Oral candidiasis pre-vention in transplantation patients: a comparative study. Clin Transplant. 2006;20(3):318–324.
   PubMed Web of Science ®Google Scholar
• Saag MS, Fessel WJ, Kaufman CA, et al. Treatment of fluconazole-refractory oropharyngeal candidiasis with itra-conazole oral solution in HIV-positive patients. AIDS Res Hum Retroviruses. 1999;15(16):1413–1417.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Truelove EL, Hanson-Huggins K, et al. Topi-cal polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy. Support Care Cancer. 2004;12(7):517–525.
   PubMed Web of Science ®Google Scholar
• Glick M, Siegel MA. Viral and fungal infections of the oral cavity in immunocompetent patients. Infect Dis Clin North Am. 1999;13(4):817–831, vi.
   PubMed Web of Science ®Google Scholar
• De Wit S, O'Doherty E, Edwards J, et al. Pharmacokinet-ics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: a phase I study. Antimicrob Agents Chemother. 1998;42(4):903–906.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006;6:21.
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Fuursted K, Gahrn-Hansen B, et al. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect. 2008;14(5):487–494.
   PubMed Web of Science ®Google Scholar
• Ruhnke M. Epidemiology of Candida alb/cans infections and role of non-Candida-albicans yeasts. Curr Drug Tar-gets. 2006;7(4):495–504.
   PubMed Web of Science ®Google Scholar
• Odds FC, Hanson MF, Davidson AD, et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol. 2007;56(Pt 8):1066–1075.
   PubMed Web of Science ®Google Scholar
• Bensadoun RJ, Daoud J, El Gueddari B, et al. Com-parison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase Ill trial in patients treated with radiotherapy for head and neck cancer. Cancer. 2008;112(1):204–211.
   PubMed Web of Science ®Google Scholar
• Farup PG. Compliance with anti-ulcer medication during short-term healing phase clinical trials. Aliment Pharmacol Ther 1992;6(2):179–186.
   PubMed Web of Science ®Google Scholar
• Carter S, Taylor D, Levenson R. A Question of Choice: Compliance in Taking Medicine. 3rd ed. Medicines Part-nership; 2005. http://www.npci.org.uk/adherence_to_medicines/atm/assess/library/library_other_publicationl.php. Accessed March 5, 2010.
   Google Scholar